Hemp compound tested for spinal cord injury pain relief

NCT ID NCT05630235

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small early-phase trial tests whether a single oral dose of a hemp-derived CBD/CBD-A extract can reduce neuropathic pain and change brain activity in people with spinal cord injury. Six participants with moderate to severe nerve pain for at least three months will receive either the extract or a placebo. The study measures pain intensity, unpleasantness, and brain electrical patterns using EEG.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

hemp-derived cannabidiol (CBD) and cannabidiolic-acid (CBD-A) oral extract

What this could lead to

If it works, this could point toward a new option for managing chronic nerve pain after spinal cord injury.

What could go wrong

This is a very small, early-phase trial with only 6 participants, so results may not apply widely. The one-time dose may not reflect real-world use, and side effects are not yet well understood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCI - SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuralgia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lynn Rehabilitation Center

    Miami, Florida, 33136, United States